News & Updates

First-line atezolizumab plus CP/ET offers survival benefits in ES-SCLC
First-line atezolizumab plus CP/ET offers survival benefits in ES-SCLC
30 May 2025 byStephen Padilla

Patients with extensive-stage small cell lung cancer (ES-SCLC) derive real-world clinical benefits from first-line treatment with atezolizumab combined with carboplatin and etoposide (CP/ET), reports a recent study.

First-line atezolizumab plus CP/ET offers survival benefits in ES-SCLC
30 May 2025
TrUST study heralds new era for TB diagnosis
TrUST study heralds new era for TB diagnosis
21 May 2025 byAudrey Abella

A suite of deep learning (DL) models to automate tuberculosis (TB) risk assessment from lung ultrasound (LUS) images fulfils the WHO criteria for a sputum-free TB triage test and outwits human experts in the TrUST study.

TrUST study heralds new era for TB diagnosis
21 May 2025
Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
17 May 2025 byJairia Dela Cruz

Placing awake COVID-19 patients with acute hypoxaemic respiratory failure (AHRF) in a prone position is an efficacious intervention in terms of both reducing mortality and preventing intubation, according to an individual participant data meta-analysis.

Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
17 May 2025